You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Harvard Business School

Last Updated: February 19, 2020

DrugPatentWatch Database Preview

CARAFATE Drug Profile

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Which patents cover Carafate, and what generic alternatives are available?

Carafate is a drug marketed by Allergan and is included in two NDAs.

The generic ingredient in CARAFATE is sucralfate. There are fourteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the sucralfate profile page.

US ANDA Litigation and Generic Entry Outlook for Carafate

A generic version of CARAFATE was approved as sucralfate by TEVA on March 29th, 1996.

  Start Trial

US Patents and Regulatory Information for CARAFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan CARAFATE sucralfate SUSPENSION;ORAL 019183-001 Dec 16, 1993 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Allergan CARAFATE sucralfate TABLET;ORAL 018333-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.